SpringWorks
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SpringWorks and other ETFs, options, and stocks.About SWTX
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor.
CEOSaqib Islam
CEOSaqib Islam
Employees368
Employees368
HeadquartersStamford, Connecticut
HeadquartersStamford, Connecticut
Founded2017
Founded2017
Employees368
Employees368
SWTX Key Statistics
Market cap3.36B
Market cap3.36B
Price-Earnings ratio-12.84
Price-Earnings ratio-12.84
Dividend yield—
Dividend yield—
Average volume3.14M
Average volume3.14M
High today$45.01
High today$45.01
Low today$44.19
Low today$44.19
Open price$44.84
Open price$44.84
Volume7.81M
Volume7.81M
52 Week high$62.00
52 Week high$62.00
52 Week low$28.21
52 Week low$28.21
SWTX News
TipRanks 2d
M&A News: Merck KGaA to Buy SpringWorks for $3.5B to Boost Oncology BusinessGermany’s Merck KGaA (DE:MRK) is in advanced talks to buy U.S.-based SpringWorks Therapeutics (SWTX) for roughly $3.5 billion, aiming to boost its oncology busi...
TipRanks 5d
Positive opinion for Ogsiveo would de-risk SpringWorks deal, says BarclaysBarclays notes that SpringWorks Therapeutics’ (SWTX) Ogsiveo was included on today’s Committee for Medicinal Products for Human Use agenda, which could lead to...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%